Pharmaceutical practice of clinical pharmacists participating in the treatment for refractory edema secondary to diabetic kidney disease / 药物流行病学杂志
Chinese Journal of Pharmacoepidemiology
; (4): 1425-1431, 2023.
Article
in Zh
| WPRIM
| ID: wpr-1023157
Responsible library:
WPRO
ABSTRACT
Clinical pharmacist participated in the whole process of combined drug treatment and medication monitoring of a patient with refractory edema secondary to end-stage diabetic kidney disease.By using dapagliflozin combined with sacubitril valsartan and conventional diuretics,the patient's body weight decreased by 16 kg,blood pressure returned to normal,systemic edema subsided and the symptoms of heart failure obviously improved.In this case,clinical pharmacist provided individualized pharmaceutical care and assisted clinicians to make a scientific and reasonable drug therapy,so as to provide a new idea and medication reference for clinical patients to delay the time of renal replacement therapy.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Pharmacoepidemiology
Year:
2023
Type:
Article